Schrödinger, Inc. is a New York-based company that specializes in the development of a physics-focused computational platform for the discovery of novel molecules for drug development and materials applications. The company comprises two segments: Software and Drug Discovery. The former is dedicated to licensing its cutting-edge software to transform the molecular discovery process, serving life sciences and materials science industries. Meanwhile, the latter is focused on generating a portfolio of preclinical and clinical programs, both in-house and through partnerships. Schrödinger, Inc. boasts a diverse customer base, including biopharmaceutical and industrial companies, academic institutions, and government laboratories across the globe. Founded in 1990, the company has since pioneered innovative solutions in the field of molecular research.
Schrödinger's ticker is SDGR
The company's shares trade on the NASDAQ stock exchange
They are based in New York City, New York
There are 201-500 employees working at Schrödinger
It is schrodinger.com
Schrödinger is in the Healthcare sector
Schrödinger is in the Healthcare Information Services industry
The following five companies are Schrödinger's industry peers: